Stock Events

Stock Events

Kymera Therapeutics (KYMR) Q3 2024 Earnings

7AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.9

-0.68

-0.47

-0.25

Details

Expected EPS

-0.681306

Actual EPS

-0.58

Surprise EPS

0.1

Surprise Percent

+14.87%

Description

Kymera Therapeutics (KYMR) has reported earnings of -0.58 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.